Surprising Insights on Clinical Trial Digital Transformation
According to a recent report, “The State Of Digital Excellence In The Global Pharmaceutical Industry, 2023: Clinical Operations,” by...
Moe Alsumidaie
Urgent Warning: Dangers and Costs of Clinical Trial Imaging Errors
Over the past 30 years, there have been significant advancements in therapies and the in clinical acquisition and measurement...
Digital Health Devices: A New Era of Clinical Trial Insight
In the rapidly evolving landscape of clinical trials, integrating Digital Health devices and digital health technologies (DHTs) has become...
Explore O2P Hydrocodone: A Groundbreaking New Path to Pain Relief
The opioid epidemic continues to wreak havoc in the United States, with over 107,000 deaths from opioid overdoses in...
Exploring AI and DCTs: A New Era of Clinical Research
In the rapidly evolving field of clinical trials, Artificial Intelligence (AI) and digital technologies play increasingly crucial roles in...
Why Did FDA Panel Reject Psychoactive MDMA-Assisted Therapy?
The FDA Panel has raised multiple critical concerns regarding Lykos Therapeutics’ MDMA-assisted therapy trials for treating PTSD, offering valuable...
ICH Shifts Strategy to Incorporate The Patient’s Persperctive
The ICH Townhall at the 2024 DIA Europe conference featured insightful discussions on the critical role of the International...
Exploring the State of Clinical Trials in Europe at DIA 2024
A 2024 DIA Europe Conference session led by Peter Richard Arlett, MD, Head of the Data Analytics and Methods...
Transforming Clinical Trials: The Surging Role of Regulatory Reliance
Regulatory reliance in regulatory frameworks refers to the practice where regulatory authorities use assessments conducted by other agencies to...
Innovative Clinical Data Management: New Horizons Unveiled
Technological advancements have become indispensable in clinical data management in the rapidly evolving clinical trials industry, especially in the...